logo
#

Latest news with #ManipalHospitals

Novo Holdings Reports Strong Momentum in Asia Across Healthcare and Planetary Health in 2024
Novo Holdings Reports Strong Momentum in Asia Across Healthcare and Planetary Health in 2024

Yahoo

time4 days ago

  • Business
  • Yahoo

Novo Holdings Reports Strong Momentum in Asia Across Healthcare and Planetary Health in 2024

Landmark investments, portfolio progress, and expanded presence positionNovo Holdings for long-term growth and impact in Asia SINGAPORE, June 18, 2025 /PRNewswire/ -- Novo Holdings today released its Asia Investments Year in Review 2024, highlighting a year of strategic growth and purpose-driven investing across healthcare, life sciences, and planetary health in key Asian markets. The report underscores Novo Holdings' commitment to building long-term partnerships that deliver both financial returns and societal impact. Now in its fifth year, the Novo Holdings Asia platform continues to strengthen its footprint across the region, with teams based in Singapore, Shanghai, and an upcoming office in Mumbai. Highlights from 2024 include: Largest-ever Asia investment in India's Manipal Hospitals, a leading provider of high-quality, affordable healthcare First Planetary Health investment in Asia, backing AgNext Technologies in India to enhance food quality and safety using AI Enhanced presence in China with the opening of an expanded office in Shanghai, reaffirming long-term regional commitment Continued support for digital health innovators, including follow-on investments in and MedGenome The Year in Review also reflects positive progress across Novo Holdings' Asia portfolio, with key portfolio milestones including FDA clearance for lung nodule detection tool, strategic acquisitions by Manipal Hospitals and Medi Assist, and the launch of Doctor Anywhere's integrated MedSuites facility in Singapore. Amit Kakar, Managing Partner and Head of Asia at Novo Holdings, said:"In 2024, we advanced our mission of investing in innovation that improves lives, through strengthening healthcare systems, advancing AI in diagnostics, and enabling more sustainable food production. These investments reflect the scale and urgency of the challenges Asia faces, and the opportunity to be part of transformative solutions. Looking ahead, we are excited to continue expanding our regional platform, deepening our partnerships, and identifying new ways to drive impact at the intersection of health, science, and sustainability." Read the full review at: About Novo HoldingsNovo Holdings is a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people's health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. Wholly owned by the Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S (formerly Novozymes A/S) and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure, and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Asia, Planetary Health, and Principal Investments teams, Novo Holdings invests in life sciences companies at all stages of development. As of year-end 2024, Novo Holdings had total assets of EUR 142 Further information: Paul Ewing-ChowHead of Corporate Affairs Asiapec@ View original content: SOURCE Novo Holdings

Patients with comorbidity push up Covid admission numbers
Patients with comorbidity push up Covid admission numbers

Time of India

time6 days ago

  • Health
  • Time of India

Patients with comorbidity push up Covid admission numbers

Kolkata: The number of Covid patients admitted due to their comorbidities rather than the virus has been increasing at several private hospitals in Kolkata, forcing at least two of them to extend their isolation units. Since a majority of these patients are undergoing prolonged treatment for their comorbidities, their stay periods are long, leaving Covid beds occupied. While new Covid admissions are few, discharges have been even slower over the past week, but not due to Covid, say the hospitals. CMRI Hospital has 14 Covid patients admitted, and Manipal Hospitals also have around 14 across its four units, including Medica Superspecialty Hospital and Manipal Mukundapur, which together have around 10 patients. Peerless Hospital has three, while Woodlands Hospital has a few as well. CMRI has just one severe Covid patient now, while the other 13 admitted have ailments that are taking time to heal. "While we admit a Covid patient every alternate day, discharges are happening every three to four days. These patients have severe comorbidities while their Covid symptoms are mild. They would have been discharged if they didn't have co-ailments," said CMRI pulmonology director Raja Dhar. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Taylor Swift, 35, Takes off Her Makeup and Leaves Us Without Words Telehealth Dave Undo CMRI plans to scale up the number of Covid beds to 32 from the existing 18 if the patient number climbs further. It now has 14 patients. "Comorbidities have been stacking up patients," said Dhar. Manipal Hospitals have multiple patients across its four units, including four at Dhakuria. "Barring a couple, the rest have lung or cardiac ailments or have hypertension and diabetes. They tested Covid positive on admission, but their Covid symptoms are mild and manageable. Yet they need to be kept in isolation," said Sayan Chakrabarty, infectious diseases physician at Manipal Dhakuria. While the Dhakuria unit now has 10 Covid beds, including five at the ICU, the Mukundapur unit has five isolation cabins, and the Salt Lake unit has another five. Both Medica and Mukundapur have elderly patients with comorbidities who tested positive on admission. Peerless Hospital had one Covid patient admitted on Saturday, down from three until Friday. "Barring a woman who was admitted with fever, we had two children with mild Covid symptoms who were treated for other ailments and discharged. One child was in ICU, but he was admitted with jaundice and tested Covid positive after admission," said Peerless Hospital CEO Sudipta Mitra. Charnock Hospital had three Covid patients, all of whom were discharged. "We mostly admitted the elderly who had comorbidities like COPD, asthma, lung, or cardiac ailments," said Charnock pulmonologist Soumya Sengupta.

Oncologists reveal who is more at risk of aggressive prostate cancer, explain why early detection is crucial
Oncologists reveal who is more at risk of aggressive prostate cancer, explain why early detection is crucial

Hindustan Times

time13-06-2025

  • Health
  • Hindustan Times

Oncologists reveal who is more at risk of aggressive prostate cancer, explain why early detection is crucial

Back in 2014, Hollywood actor Ben Stiller was diagnosed with prostate cancer. Over the last few years, he tried to raise awareness about how early-detection helped save his life. Even veteran actor Robert De Niro is and former President of South Africa, Nelson Mandela, who died in 2013, was a prostate cancer survivor. Also read | Joe Biden diagnosed with 'aggressive' prostate cancer: All you need to know, from symptoms to cause Prostate cancer is a type of cancer that affects the prostate gland in men. In an interview with HT Lifestyle, Dr Rama Krishna, consultant in radiation oncology at Manipal Hospitals, Vijayawada, and Dr Manohar Bhadrappa, senior consultant in chief of urology, renal transplant surgeon, and uro-oncology surgeon at Manipal Hospital Sarjapur Road, explained that prostate cancer is treatable when detected early, and patients have a wider range of options available to them. Dr Krishna said that prostate cancer is one of the most common cancers in men, with 'one in six men affected during their lifetime': 'As per the Indian Council of Medical Research, around 47,000 new cases are diagnosed annually in India, accounting for 3 percent of all cancer cases. This number is expected to rise over the next 10 to 20 years due to increasing life expectancy and improved access to affordable healthcare.' Dr Bhadrappa added that approximately 15 percent of prostate cancer cases fall into the high-risk category. He said, 'These are more aggressive, with a greater chance of becoming life-threatening. While some tumours remain localised and indolent, high-risk or locally advanced cancers — defined by clinical stage T2c or higher, Gleason score of 8 or more, PSA over 20 ng/mL, or over 33 percent positive biopsy samples — require aggressive treatment.' 'Age is the most significant risk factor for prostate cancer, but increasing use of screening, heightened awareness, and factors such as family history, race, and genetics also contribute to its rising incidence. Men with a close relative diagnosed at a younger age, particularly in their 50s, are at significantly higher risk,' Dr Krishna said. He also dispelled common myths, noting that while prostate cancer is more prevalent in the elderly, 'recent data shows growing detection rates in men in their late 40s and early 50s'. 'These younger patients often present a more aggressive or advanced disease. Lack of symptoms does not mean absence of disease, as many men diagnosed with prostate cancer report only mild or vague urinary issues,' Dr Krishna said. Although there are no clearly modifiable risk factors, he stressed that regular screening is essential. 'Prostate cancer grows slowly and responds well to treatment, allowing time for effective management — provided it is detected early. Average-risk men should start screening at age 60, and high-risk individuals with family history or genetic predispositions should begin at age 50. A yearly PSA blood test is a simple way to detect risk; elevated levels should be followed by further testing as advised by a doctor,' Dr Krishna said. Dr Bhadrappa also highlighted the importance of early detection, advising PSA screening to begin at age 50 for most men, at 45 for those with a family history of prostate cancer, and at 40 if there's a family history of both breast and prostate cancers. He said, 'For high-risk patients, radical prostatectomy is the most effective treatment. This surgery involves full removal of the prostate, ensuring negative surgical margins, and extended pelvic lymph node dissection. Outcomes are best when performed by experienced urologic surgeons.' Dr Bhadrappa added that in patients with rapidly doubling PSA levels, 'cancer may spread within a year, and survival drops to 3-4 years'. He added, 'Yet, about 77 percent of high-risk patients, who undergo surgery, live beyond 10 years, proving that timely and expert intervention can significantly improve prognosis. Spot it early.' Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.

Renowned Gynaecologist Joins Manipal Hospital Gurugram to Strengthen Women's Health
Renowned Gynaecologist Joins Manipal Hospital Gurugram to Strengthen Women's Health

Business Standard

time12-06-2025

  • Health
  • Business Standard

Renowned Gynaecologist Joins Manipal Hospital Gurugram to Strengthen Women's Health

PRNewswire Gurugram (Haryana) [India], June 12: Manipal Hospital, one of the leading healthcare institutions in Gurugram, welcomes renowned surgeon Dr Amita Shah, Chairman & HOD, Obstetrics & Gynecology, Laparoscopy Endoscopy. Dr Shah has joined the expert team of Manipal Hospital Gurugram, to strengthen and enhance the medical expertise of healthcare delivery to the people of Gurugram. Through dedicated women's wellness and preventive health initiatives, she contributes to early detection and long-term health planning. Dr Amita Shah will further enhance Manipal Hospital's expertise with extensive knowledge and experience spanning more than 29 years in diagnosing and treating numerous complex gynaecological issues. She is an expert in procedures like 3D and Robotic-Assisted Laparoscopic Gynaecological Surgeries, Gynae Oncology - Screening & Management, Infertility & Reproductive Endocrinology and many more. Her focus is to provide preventive health, advanced management of gynaecological disorders, and fertility care through a dedicated specialty clinic that has cutting-edge technology to treat advanced gynaecological issues. She is an active member of the Indian Fertility Society (IFS) and the Indian Association of Gynae Endoscopists (IAGE). Her addition to the team strengthens the hospital's capabilities in providing comprehensive heart care. Dr Shah practices a 360-degree approach to women's health, providing care from conception through childbirth and postnatal vaccination, making Manipal Hospital a one-stop destination for maternity and reproductive care. She will play a key role in various Obstetrics and Gynecological programs such as Spandan, a parent support initiative aimed at easing the journey of parenthood through expert-led educational sessions and Manipal Sakhi, a comprehensive health card packed with exclusive patient benefits for women. Expressing his enthusiasm for joining the team, Navin Pascal, Hospital Director, Manipal Hospital, Gurugram, said, "We are delighted to have Dr Amita Shah in our team of medical experts. With a wealth of experience in women's healthcare, Dr. Shah brings with her a deep commitment to clinical excellence and patient-centered care. Her expertise across complex gynaecological procedures, high-risk obstetrics, and holistic reproductive health makes her a valuable addition to our multidisciplinary team. With her being a part of Manipal Hospital, we will be able to deliver advanced clinical management of gynaecological disorders, including minimally invasive and robotic surgeries for faster recovery and improved outcomes. At Manipal Hospital, we are dedicated to continuously enhancing the quality and scope of our healthcare services. Her joining marks a significant step in our ongoing efforts to elevate healthcare standards in Gurugram and assure our position as a trusted leader in women's health." About Manipal Hospitals As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out of hospital care. With the completion of acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 37 hospitals across 19 cities with 10,500+ beds, and a talented pool of 5,600+ doctors and an employee strength of over 18,600. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH, AAHRPP accredited and most of the hospitals in its network are NABL, ER, Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognised the most respected and patient recommended hospital in India through various consumer surveys

Renowned Gynaecologist Joins Manipal Hospital Gurugram to Strengthen Women's Health
Renowned Gynaecologist Joins Manipal Hospital Gurugram to Strengthen Women's Health

Malaysian Reserve

time12-06-2025

  • Health
  • Malaysian Reserve

Renowned Gynaecologist Joins Manipal Hospital Gurugram to Strengthen Women's Health

GURUGRAM, India, June 12, 2025 /PRNewswire/ — Manipal Hospital, one of the leading healthcare institutions in Gurugram, welcomes renowned surgeon Dr Amita Shah, Chairman & HOD, Obstetrics & Gynecology, Laparoscopy Endoscopy. Dr Shah has joined the expert team of Manipal Hospital Gurugram, to strengthen and enhance the medical expertise of healthcare delivery to the people of Gurugram. Through dedicated women's wellness and preventive health initiatives, she contributes to early detection and long-term health planning. Dr Amita Shah will further enhance Manipal Hospital's expertise with extensive knowledge and experience spanning more than 29 years in diagnosing and treating numerous complex gynaecological issues. She is an expert in procedures like 3D and Robotic-Assisted Laparoscopic Gynaecological Surgeries, Gynae Oncology – Screening & Management, Infertility & Reproductive Endocrinology and many more. Her focus is to provide preventive health, advanced management of gynaecological disorders, and fertility care through a dedicated specialty clinic that has cutting-edge technology to treat advanced gynaecological issues. She is an active member of the Indian Fertility Society (IFS) and the Indian Association of Gynae Endoscopists (IAGE). Her addition to the team strengthens the hospital's capabilities in providing comprehensive heart care. Dr Shah practices a 360-degree approach to women's health, providing care from conception through childbirth and postnatal vaccination, making Manipal Hospital a one-stop destination for maternity and reproductive care. She will play a key role in various Obstetrics and Gynecological programs such as Spandan, a parent support initiative aimed at easing the journey of parenthood through expert-led educational sessions and Manipal Sakhi, a comprehensive health card packed with exclusive patient benefits for women. Expressing his enthusiasm for joining the team, Navin Pascal, Hospital Director, Manipal Hospital, Gurugram, said, 'We are delighted to have Dr Amita Shah in our team of medical experts. With a wealth of experience in women's healthcare, Dr. Shah brings with her a deep commitment to clinical excellence and patient-centered care. Her expertise across complex gynaecological procedures, high-risk obstetrics, and holistic reproductive health makes her a valuable addition to our multidisciplinary team. With her being a part of Manipal Hospital, we will be able to deliver advanced clinical management of gynaecological disorders, including minimally invasive and robotic surgeries for faster recovery and improved outcomes. At Manipal Hospital, we are dedicated to continuously enhancing the quality and scope of our healthcare services. Her joining marks a significant step in our ongoing efforts to elevate healthcare standards in Gurugram and assure our position as a trusted leader in women's health.' About Manipal Hospitals As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out of hospital care. With the completion of acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 37 hospitals across 19 cities with 10,500+ beds, and a talented pool of 5,600+ doctors and an employee strength of over 18,600. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH, AAHRPP accredited and most of the hospitals in its network are NABL, ER, Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognised the most respected and patient recommended hospital in India through various consumer surveys Photo – – –

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store